Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Moodys
McKinsey
Federal Trade Commission
Farmers Insurance
Cipla

Generated: September 19, 2019

DrugPatentWatch Database Preview

Details for Patent: 9,950,125

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,950,125
Title:Needle assisted jet injection administration of testosterone compositions
Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
Inventor(s): Wotton; Paul K. (Newtown, PA), Dave; Kaushik J. (Edison, NJ), Hayes; John W. (Chaska, MN), Sadowski; Peter L. (Woodbury, MN), Jooste; Hermanus L. (Wayne, PA), Jaffe; Jonathan (Annandale, NJ)
Assignee: ANTARES PHARMA, INC. (Ewing, NJ)
Application Number:13/857,859
Patent Claim Types:
see list of patent claims
 

Drugs Protected by US Patent 9,950,125

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-001 Sep 28, 2018 RX Yes Yes ➤ Sign Up ➤ Sign Up Y METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY ➤ Sign Up
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-002 Sep 28, 2018 RX Yes Yes ➤ Sign Up ➤ Sign Up Y METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY ➤ Sign Up
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-003 Sep 28, 2018 RX Yes Yes ➤ Sign Up ➤ Sign Up Y METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY ➤ Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 9,950,125

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2013203784 ➤ Sign Up
Canada 2868500 ➤ Sign Up
Canada 2900672 ➤ Sign Up
China 104487114 ➤ Sign Up
European Patent Office 2731645 ➤ Sign Up
European Patent Office 2833944 ➤ Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Merck
McKesson
Argus Health
Queensland Health
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.